Lepu Biopharma Co., Ltd. (02157) has published its monthly return for the period ended 31 October 2025. The announcement indicates that the company’s authorized share capital remains at 1,804,439,838 ordinary H shares, each with a par value of RMB 1. The total authorized capital therefore remains at RMB 1,804,439,838.

The monthly return further shows that the issuer’s total number of issued shares stands at 1,804,439,838, with no shares held in treasury. According to the report, there were no movements in share options, warrants, convertibles, or any other agreements to issue shares during the period. The filing confirms compliance with all applicable listing rules and regulatory requirements, underscoring that no capital structure changes occurred during October 2025.